CopyMark Law Group
4.9/5
Drawing for LUMISENSE

USPTO serial 79367837

LUMISENSE

Reviewed by CopyMark Law Group

Reg. 7452179Status 700Registered
Filing date
Status date
Registration date
Jul 23, 2024
Examiner
MAHMOUDI, MARIAM AZIZ
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LUMISENSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Clifford D Hyra

Clifford D Hyra Fresh IP PLC11710 Plaza America Drive Suite 2000Reston, VA 20190United States

Goods and services

ClassDescriptionStatusFirst use
005Cells for medical or clinical use; personalized autologous or allogeneic cell-based therapies in the nature of cells for medical use; biological preparations for use in cell cultures for medical applications; pharmaceutical preparations and substances for the treatment of genetic diseases in the nature of single-gene disorders, immunological diseases and cancer; pharmaceutical preparations and substances for applications in tissue engineering and regenerative medicine for cell transplantation, stem cell therapy and gene therapy; reagents for medical use; biological reagents for medical use; diagnostic reagents for medical use; reagents for use in medical genetic testing; stem cells for medical purposes; engineered medicinal cell-based products, cell lines and biomolecules, namely, genetically engineered cells for medical use; medical reagents contained in a cartridge for medical diagnostic useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 1, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 15, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 15, 2025FIMPFINAL DISPOSITION PROCESSED—
Oct 23, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 23, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 23, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 8, 2024GPNXNOTIFICATION PROCESSED BY IB—
May 7, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 7, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 17, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 17, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 17, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 3, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 2, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 2, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 2, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 21, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 21, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 21, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 21, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 21, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 21, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 4, 2023RFNPREFUSAL PROCESSED BY IB—
Nov 16, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 16, 2023RFRRREFUSAL PROCESSED BY MPU—
Nov 16, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 15, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 14, 2023DOCKASSIGNED TO EXAMINER—
Jun 4, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 25, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 21, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 20, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance